×
The email you entered is not valid.
Culture

Why Are Vaccines Taking Longer Than They Should?

Source: https://www.reveliolabs.com/blog/p9emh1g6gslppqbyz0erofr14f1qdg

There has been tremendous speculation about when a COVID-19 vaccine will be ready and what pharmaceutical companies will be involved in the manufacturing and distribution. It would be hard to find anyone whose well-being would not be dramatically improved by a vaccine.

By looking into the skills of scientists at major pharma companies, we’re able unearth a surprising trend that skills related to vaccines have been on a long-term decline since 2011, a trend that has only recently started to reverse.

Below we can see that scientists have been growing in top pharma companies across the board:

And yet, below is the subset of scientists with skills in vaccines:

Takeaways:

  • Skills in vaccines have fallen from a previous peak in November 2011 by over 17%, a time when overall scientists have increased by 25%.
  • Of the top pharma companies, there are only three companies with significant vaccine teams: Pfizer, GSK, and Merck, while many other large pharma companies have not invested in vaccine research.
  • Vaccines are somewhat of a niche area compared to many other priorities. For example, there are about 15,000 scientists across these companies skilled in vaccines, compared to about 50,000 for oncology research.

To learn more about the data behind this article and what Revelio Labs has to offer, visit https://www.reveliolabs.com/.

GET WEEKLY ALERTS

Sign up to receive our stories in your inbox.

The email you entered is not valid.

LET US HELP

Data is changing the speed of business. Investors, Corporations, and Governments are buying new, differentiated data to gain visibility make better decisions. Don't fall behind. Let us help.

DATA PROVIDER SPOTLIGHT

Datamyne

Founded in 1992 with the aim of accurately documenting import‐export transactions in the Americas, built and maintained by an international team, Descartes Datamyne today is a top‐ranked provider in the highly competitive US market for trade data.

GET WEEKLY ALERTS

Sign up to receive our stories in your inbox.

The email you entered is not valid.

LET US HELP

Data is changing the speed of business. Investors, Corporations, and Governments are buying new, differentiated data to gain visibility make better decisions. Don't fall behind. Let us help.

DATA PROVIDER SPOTLIGHT

Datamyne

Founded in 1992 with the aim of accurately documenting import‐export transactions in the Americas, built and maintained by an international team, Descartes Datamyne today is a top‐ranked provider in the highly competitive US market for trade data.